Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Astrazeneca plc - ADR
Swot
Astrazeneca plc - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Astrazeneca plc - ADR has 9 Strengths, 8 Weaknesses, 2 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(8)
Opportunity
(2)
Threats
(1)
Others
(2)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Relative Outperformance versus Industry over 1 Week
Annual Profit Growth higher than Sector Profit Growth
Relative Outperformance versus Industry over 1 Week
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Increasing profits every quarter for the past 2 quarters
Stocks with Quarter Change % less than Industry
PE higher than Industry PE
PEG greater than Industry PEG
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Top Losers
Low Piotroski Score : Companies with weak financials
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter
Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks